|
Name |
Rhizoctonic acid
|
Molecular Formula | C17H16O7 | |
IUPAC Name* |
5-hydroxy-2-(2-hydroxy-6-methoxy-4-methylbenzoyl)-3-methoxybenzoic acid
|
|
SMILES |
CC1=CC(=C(C(=C1)OC)C(=O)C2=C(C=C(C=C2OC)O)C(=O)O)O
|
|
InChI |
InChI=1S/C17H16O7/c1-8-4-11(19)15(12(5-8)23-2)16(20)14-10(17(21)22)6-9(18)7-13(14)24-3/h4-7,18-19H,1-3H3,(H,21,22)
|
|
InChIKey |
WAVNWOVGGNONJD-UHFFFAOYSA-N
|
|
Synonyms |
Rhizoctonic acid
|
|
CAS | NA | |
PubChem CID | 46216851 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 332.3 | ALogp: | 2.9 |
HBD: | 3 | HBA: | 7 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 113.0 | Aromatic Rings: | 2 |
Heavy Atoms: | 24 | QED Weighted: | 0.721 |
Caco-2 Permeability: | -5.236 | MDCK Permeability: | 0.00000642 |
Pgp-inhibitor: | 0.004 | Pgp-substrate: | 0.038 |
Human Intestinal Absorption (HIA): | 0.197 | 20% Bioavailability (F20%): | 0.143 |
30% Bioavailability (F30%): | 0.799 |
Blood-Brain-Barrier Penetration (BBB): | 0.062 | Plasma Protein Binding (PPB): | 93.67% |
Volume Distribution (VD): | 0.522 | Fu: | 5.09% |
CYP1A2-inhibitor: | 0.421 | CYP1A2-substrate: | 0.874 |
CYP2C19-inhibitor: | 0.04 | CYP2C19-substrate: | 0.055 |
CYP2C9-inhibitor: | 0.333 | CYP2C9-substrate: | 0.184 |
CYP2D6-inhibitor: | 0.182 | CYP2D6-substrate: | 0.153 |
CYP3A4-inhibitor: | 0.119 | CYP3A4-substrate: | 0.111 |
Clearance (CL): | 8.742 | Half-life (T1/2): | 0.839 |
hERG Blockers: | 0.036 | Human Hepatotoxicity (H-HT): | 0.177 |
Drug-inuced Liver Injury (DILI): | 0.987 | AMES Toxicity: | 0.099 |
Rat Oral Acute Toxicity: | 0.04 | Maximum Recommended Daily Dose: | 0.28 |
Skin Sensitization: | 0.15 | Carcinogencity: | 0.029 |
Eye Corrosion: | 0.004 | Eye Irritation: | 0.663 |
Respiratory Toxicity: | 0.69 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC006012 | 1.000 | D06GCK | 0.343 | ||||
ENC002468 | 0.819 | D0E6OC | 0.337 | ||||
ENC005978 | 0.819 | D07MGA | 0.316 | ||||
ENC000936 | 0.730 | D00WVW | 0.298 | ||||
ENC005416 | 0.684 | D00KRE | 0.292 | ||||
ENC001490 | 0.679 | D06TQZ | 0.276 | ||||
ENC005977 | 0.619 | D0QD1G | 0.276 | ||||
ENC004806 | 0.617 | D09DHY | 0.274 | ||||
ENC005979 | 0.617 | D0W7JZ | 0.270 | ||||
ENC006015 | 0.614 | D0Y7PG | 0.269 |